GTX-102, GTX/UX Diluent and Flush Solution
GTX-102-CL210
Phase 2 small_molecule active
Quick answer
GTX-102, GTX/UX Diluent and Flush Solution for Angelman Syndrome is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Angelman Syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active